Stock EQS EQUASENS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Equasens

Equities

EQS

FR0012882389

Real-time Euronext Paris
Other stock markets
 09:39:15 2024-07-03 am EDT 		5-day change 1st Jan Change
52.6 EUR +1.15% Intraday chart for Equasens -4.36% -13.91%
Jun. 03 Stifel Upgrades Equasens to Buy from Hold, Boosts PT MT
Jun. 03 Equasens: upbeat on broker upgrade CF

Evolution of the average Target Price on Equasens

Price target over the last 5 years

History of analyst recommendation changes

e65709bcb85bef.7QD--oP9bythoGqxC4KK2b0aJLCARRhx6ETrlf_RrVU.izLJtvu3X0IE9AH9fdvzloR-SITNGmAQvnaG0qCf3CSPSKat1agAUVSUDQ~9c3838cce76073a9c5cc192b10ad67d8

Analyst Recommendations on Equasens

Stifel Upgrades Equasens to Buy from Hold, Boosts PT MT
Equasens: upbeat on broker upgrade CF
EQUASENS : Stifel raises its recommendation CF
Equasens: share price up, broker confirms its recommendation CF
EQUASENS : Stifel maintains its recommendation on the share CF
EQUASENS : Stifel lowers its target price CF
Stifel Cuts Equasens PT, Affirms Hold Rating MT
EQUASENS : Stifel lowers its target price CF
EQUASENS : Stifel adjusts target after sales figures CF
Pharmagest Interactive : Group wins the top prize in its category of the 2019 GAÏA Rating for its ESG performances PU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
52 EUR
Average target price
71.48 EUR
Spread / Average Target
+37.47%
High Price Target
83 EUR
Spread / Highest target
+59.62%
Low Price Target
58 EUR
Spread / Lowest Target
+11.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Equasens

Stifel Nicolaus

Ratings for Equasens

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EQS Stock
  4. Consensus Equasens